Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion.

Other Article

Full Text

Duke Authors

Cited Authors

  • Hamilton, E; Blackwell, K; Hobeika, AC; Clay, TM; Broadwater, G; Ren, XR; Chen, W; Castro, H; Lehmann, F; Spector, N; Wei, J; Osada, T; Lyerly, HK; Morse, MA

Published Date

  • 2013

Published In

Volume / Issue

  • 11 /

Start / End Page

  • 82 -

PubMed ID

  • 23536971

Pubmed Central ID

  • PMC:PMC3618320

Electronic International Standard Serial Number (EISSN)

  • 1479-5876

Digital Object Identifier (DOI)

  • 10.1186/1479-5876-11-82

Language

  • eng

Conference Location

  • England